CoChat

Lowered Tumor Necrosis Factor Receptors, but Not Increased Insulin Sensitivity, with Infliximab

Open access
Di Rocco, Paola, Manco, Melania, Rosa, Giuseppina, Greco, Aldo V., Mingrone, Geltrude · 2004 · Obesity Research
Cited by 49

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Objectives: To verify whether Infliximab could modify insulin sensitivity and TNF‐α and GLUT4 mRNA expression in muscle and adipose tissue of morbidly obese subjects. Soluble TNF receptors I and II (TNFR‐I and TNFR‐II) were also assayed. Research Methods and Procedures: Six obese subjects were investigated before and 2 weeks after a single intravenous administration of 5 mg/kg Infliximab; insulin sensitivity was evaluated by euglycemic hyperinsulinemic clamp, and TNF‐α and GLUT4 mRNA expression were assessed by reverse‐transcriptase polymerase chain reaction on muscle and adipose tissue. TNF‐α, TNFR‐I, and TNFR‐II were determined using the ELISA technique. Results: Infliximab infusion did not affect fasting plasma insulin or fasting plasma glucose levels; whole body glucose uptake did not change significantly. TNF‐α and GLUT4 mRNA did not show any significant change in muscle or adipose tissue. Serum TNF‐α was undetectable before and after treatment, whereas TNFR‐I and TNFR‐II concentrations significantly decreased (p < 0.01). Discussion: An explanation for the absence of effect of Infliximab on insulin resistance in morbidly obese subjects may be the paracrine way of action of this cytokine. Because Infliximab is predominantly distributed within the vascular compartment, its effectiveness in penetrating muscle and adipose tissue is potentially low. The significant decrease of TNFR‐I and TNFR‐II might be ascribed to a targeted effect of Infliximab on the immune system.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/oby.2004.86

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 49

Metadata

Authors
Di Rocco, P., Manco, M., Rosa, G., Greco, A. V., & Mingrone, G.
Venue
Obesity Research
Publisher
Wiley
Published
2004-04
Volume
12
Issue
4
Pages
734-739
ISSN
  • 1071-7323 (ISSN-L)
  • 1550-8528
OpenAlex
W2118330616
Cited by
49
References
4
FWCI
3.83
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lowered Tumor Necrosis Factor Receptors, but Not Increased Insulin Sensitivity, with Infliximab. https://app.cochat.ai/papers/10.1038/oby.2004.86
The paper
Di Rocco, P., Manco, M., Rosa, G., Greco, A. V., & Mingrone, G. (2004). Lowered Tumor Necrosis Factor Receptors, but Not Increased Insulin Sensitivity, with Infliximab. Obesity Research. https://doi.org/10.1038/oby.2004.86

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.